Bexitrol F 25/ HFA Inhaler (MDI): HFA (Hydrofluoroalkane) based metered dose inhaler containing 25mcg of salmeterol xinafoate BP and mcg of. Bexitrol F drug information: Actions, Administration, Pharmacology. Bexitrol F HFA (MDI) Inhaler. Salmeterol + Fluticasone Propionate. (25 mcg+ mcg)/Metered Inhalation. Beximco Pharmaceuticals Ltd. Bexitrol F Evohaler should Bexiyrol discontinued immediately, the patient assessed and alternative therapy instituted if necessary. Please check for these effects on your body when using Bexitrol-F Inhaler. If it is close Bexitrol the time of your next Bsxitrol, skip the missed dose and Amoxi your dosing schedule. Patients of black African or Afro-Caribbean ancestry should therefore be asked to continue treatment but to seek medical advice if asthma symptoms remain uncontrolled or worsen whilst using Bexitrol F. Please do not use Bexitrol-F Inhaler for asthma and exercise-induced bronchospasm without consulting first with your doctor. Patients should continue to use the same make of spacer device as switching between spacer devices can result in changes in the dose delivered to the lungs. Candidiasis of the mouth and throat Pneumonia Bronchitis Oesophageal candidiasis. Acute: Acute inhalation of fluticasone propionate doses in excess of those recommended may lead to temporary suppression of adrenal function. Please consult your doctor to discuss changes in your dosing schedule or a new schedule to make up for missed doses, if you have missed too many doses recently. In these cases, the recommended initial dose is two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily. Melanie Mcgrice, Leading Australian fertility and prenatal dietitian.